Harutyun Sahakyan

Dr. Harutyun Sahakyan

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2021 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Closed access
PDF file
HSHarutyun Sahakyan
Harutyun Sahakyan

29 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
KWKatrien Willegems
Katrien Willegems
JEJodene Eldstrom
Jodene Eldstrom
EKEfthimios Kyriakis
Efthimios Kyriakis
FAFariba Ataei
Fariba Ataei
HSHarutyun Sahakyan
Harutyun Sahakyan
DFDavid Fedida
David Fedida
The KCNQ1 ion channel plays critical physiological roles in electrical excitability and K+recycling in organs including the heart, brain, and gut. Loss of function is relatively common and can cause sudden arrhythmic death, sudden infant death, epilepsy and deafness. Here, we report cryogenic electron microscopic (cryo-EM) structures ofXenopusKCNQ1 bound to Ca2+/Calmodulin, with and without the KCNQ1 channel activator, ML277. A single binding site for ML277 was identified, localized to a pocket lined by the S4-S5 linker, S5 and S6 helices of two separate subunits. Several pocket residues are not conserved in other KCNQ isoforms, explaining specificity. MD simulations and point mutations support this binding location for ML277 in open and closed channels and reveal that prevention of inactivation is an important component of the activator effect. Our work provides direction for therapeutic intervention targeting KCNQ1 loss of function pathologies including long QT interval syndrome and seizures.

3 August 2023 in ACS Omega
Verified
Journal Article
Open access
ASArsen Sargsyan
Arsen Sargsyan
HSHarutyun Sahakyan
Harutyun Sahakyan
KNKaren Nazaryan
Karen Nazaryan
Microtubules are dynamic, non-covalent polymers consisting of α- and β-tubulin subunits that are involved in a wide range of intracellular processes. The polymerization and dynamics of microtubules are regulated by many factors, including small molecules that interact with different sites on the tubulin dimer. Colchicine binding site inhibitors (CBSIs) destabilize microtubules and inhibit tubulin polymerization, leading to cell cycle arrest. Because of their therapeutic potential, the molecular mechanism of CBSI function is an area of active research. Nevertheless, important details of this mechanism have yet to be resolved. In this study, we use atomistic molecular dynamics simulations to show that the binding of CBSIs to the tubulin heterodimer leads to the weakening of tubulin intersubunit interaction. Using atomistic molecular dynamics simulations and binding free energy calculations, we show that CBSIs act as protein-protein interaction inhibitors and destabilize interlinkage between α and β subunits, which is crucial for longitudinal contacts in the microtubule lattice. Our results offer new insight into the mechanisms of microtubule polymerization inhibition by colchicine and its analogs.

31 October 2019 in Molecules
Verified
Journal Article
Open access
PDF file
SSSamvel N. Sirakanyan
Samvel N. Sirakanyan
DSDomenico Spinelli
Domenico Spinelli
Athina GeronikakiAthina Geronikaki
Athina Geronikaki
EHElmira K. Hakobyan
Elmira K. Hakobyan
HSHarutyun Sahakyan
Harutyun Sahakyan
AHAnush Ashot Hovakimyan
Anush Ashot Hovakimyan
Continuing our research in the field of new heterocyclic compounds, herein we report on the synthesis and antitumor activity of new amino derivatives of pyrido[3′,2′:4,5](furo)thieno[3,2-d]pyrimidines as well as of two new heterocyclic systems: furo[2–e]imidazo[1,2-c]pyrimidine and furo[2,3-e]pyrimido[1,2-c]pyrimidine. Thus, by refluxing the 8-chloro derivatives of pyrido[3′,2′:4,5]thieno(furo)[3,2-d]pyrimidines with various amines, the relevant pyrido[3′,2′:4,5]thieno(furo)[3,2-d]pyrimidin-8-amines were obtained. Further, the cyclization of some amines under the action of phosphorus oxychloride led to the formation of new heterorings: imidazo[1,2-c]pyrimidine and pyrimido[1,2-c]pyrimidine. The possible antitumor activity of the newly synthesized compounds was evaluated in vitro. The biological tests evidenced that some of them showed pronounced antitumor activity. A study of the structure–activity relationships revealed that the compound activity depended mostly on the nature of the amine fragments. A docking analysis was also performed for the most active compounds.

21 February 2023 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
AAAstghik Abrahamyan
Astghik Abrahamyan
JEJodene Eldstrom
Jodene Eldstrom
HSHarutyun Sahakyan
Harutyun Sahakyan
NKNare Karagulyan
Nare Karagulyan
LMLiana Mkrtchyan
Liana Mkrtchyan
VVVitya Vardanyan
Vitya Vardanyan
KCNQ1 voltage-gated K+ channels are involved in a wide variety of fundamental physiological processes and exhibit the unique feature of being markedly inhibited by external K+. Despite the potential role of this regulatory mechanism in distinct physiological and pathological processes, its exact underpinnings are not well understood. In this study, using extensive mutagenesis, molecular dynamics simulations, and single-channel recordings, we delineate the molecular mechanism of KCNQ1 modulation by external K+. First, we demonstrate the involvement of the selectivity filter in the external K+ sensitivity of the channel. Then, we show that external K+ binds to the vacant outermost ion coordination site of the selectivity filter inducing a diminution in the unitary conductance of the channel. The larger reduction in the unitary conductance compared to whole-cell currents suggests an additional modulatory effect of external K+ on the channel. Further, we show that the external K+ sensitivity of the heteromeric KCNQ1/KCNE complexes depends on the type of associated KCNE subunits.

1 January 2021 in Emerging Microbes & Infections
Verified
Journal Article
Open access
SSSamvel N. Sirakanyan
Samvel N. Sirakanyan
EAErik Arabyan
Erik Arabyan
AHAstghik Hakobyan
Astghik Hakobyan
THTamara Hakobyan
Tamara Hakobyan
GCGarri Chilingaryan
Garri Chilingaryan
HZHovakim Zakaryan
Hovakim Zakaryan
African swine fever virus (ASFV) is the causal agent of a fatal disease of domestic swine for which no effective antiviral drugs are available. Recently, it has been shown that microtubule-targeting agents hamper the infection cycle of different viruses. In this study, we conducted in silico screening against the colchicine binding site (CBS) of tubulin and found three new compounds with anti-ASFV activity. The most promising antiviral compound (6b) reduced ASFV replication in a dose-dependent manner (IC50 = 19.5 μM) with no cellular (CC50 > 500 μM) and animal toxicity (up to 100 mg/kg). Results also revealed that compound 6b interfered with ASFV attachment, internalization and egress, with time-of-addition assays, showing that compound 6b has higher antiviral effects when added within 2–8 h post-infection. This compound significantly inhibited viral DNA replication and disrupted viral protein synthesis. Experiments with ASFV-infected porcine macrophages disclosed that antiviral effects of the compound 6b were similar to its effects in Vero cells. Tubulin polymerization assay and confocal microscopy demonstrated that compound 6b promoted tubulin polymerization, acting as a microtubule-stabilizing, rather than a destabilizing agent in cells. In conclusion, this work emphasizes the idea that microtubules can be targets for drug development against ASFV.